"TIDES has always been an excellent forum for education."
- Nadim Akhtar, Ph.D., Senior Scientist, Astra Zeneca, United Kingdom

"The TIDES conference is the place to be to learn new technologies related to the peptide industry and to network with some of the world leaders in the field."
- Nicolas Mourier, Ph.D., Director of Product Development, Peptimmune, Inc.

"Year after year TIDES continues the be THE conference that highlights the development of peptide and oligonucleotide therapeutic drugs as well as features the importance of "TIDES" reagents in the diagnostic industry."
- Michael McGinley, Bioseparations Product Manager, Phenomenex

"Given the industry's infancy in developing oligonucleotide therapeutics, the TIDES conference provides an extremely valuable way to stay up to date and interact with colleagues involved with this fast-moving landscape."
- Daren S. Levin, Ph.D., Investigator, Inhaled Product Development, GlaxoSmithKline